EMA Says Heart Inflammation Likely Linked To mRNA-Based COVID-19 Vaccines – Yahoo Finance

Motley Fool

Over the past five years, biotech stocks have somewhat underperformed the S&P 500 benchmark. Controversies regarding drug pricing, the rising cost of innovation in medicine, and increased generic competition have all been chipping away at companies' bottom lines in the sector. Let's have a look at three such players -- Pfizer(NYSE: PFE),Regeneron Pharmaceuticals(NASDAQ: REGN), andBayer (OTC: BAYR.Y) -- and why they are fantastic choices for investors on the hunt for value.

Read the original here:

EMA Says Heart Inflammation Likely Linked To mRNA-Based COVID-19 Vaccines - Yahoo Finance

Related Posts
Tags: